Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 6c; reaffirms guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $770.4 million versus the consensus estimate of $768.99 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2024 revenue of $3.075 billion, versus the consensus of $3.086 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c